share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Meeshanthini

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Meeshanthini

4/A：持股變動聲明(修正)-高管 Dogan Meeshanthini
美股SEC公告 ·  10/08 22:46

牛牛AI助理已提取核心訊息

On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.
On September 6, 2024, Meeshanthini Dogan, the Chief Executive Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed a purchase of company stock. The transaction involved the acquisition of 68,965 shares of common stock at a price of $0.29 per share. Following this transaction, Dogan's direct holdings in the company increased to a total of 1,655,429 shares. The purchase, conducted on the open market, reflects the CEO's direct investment in the company's stock and is a matter of record for investors monitoring insider activity.
2024年9月6日，Cardio Diagnostics Holdings, Inc. [CDIO]的首席執行官Meeshanthini Dogan完成了公司股票的購買。該交易涉及以每股0.29美元的價格收購68,965股普通股。在這筆交易後，Dogan在公司的直接持股增至總共1,655,429股。這次在公開市場上進行的購買反映了首席執行官對公司股票的直接投資，是投資者監控內部人員活動的記錄事項。
2024年9月6日，Cardio Diagnostics Holdings, Inc. [CDIO]的首席執行官Meeshanthini Dogan完成了公司股票的購買。該交易涉及以每股0.29美元的價格收購68,965股普通股。在這筆交易後，Dogan在公司的直接持股增至總共1,655,429股。這次在公開市場上進行的購買反映了首席執行官對公司股票的直接投資，是投資者監控內部人員活動的記錄事項。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間